티앤엘

340570KOSDAQ의료용품 및 기타 의약 관련제품 제조업

61.6 / 100

Reference Date: 2026-07-24

Financial Score25.0 / 40

News Sentiment15.6 / 25

Momentum11.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Slightly up 4.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

T&L is a high-performance material specialist company producing and selling wound dressings (hydrocolloid, polyurethane foam), microneedles, and orthopedic fixation materials. Its flagship product, wound dressings, protect wounds and prevent fluid loss, with plans to expand into dermocosmetics and pharmaceutical markets using its material technology.

Number of Employees

237people

Average Salary

76.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

11.87Industry Average 15.185.0Point

In line with industry avg

PBR

2.25Industry Average 1.090.0Point

2.1x industry avg (risky)

ROE

20.44Industry Average -4.893.5Point

Well below industry avg

Debt Ratio

0.36Industry Average 6.868.0Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲22.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲33.0% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 24.9% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 1Negative 0Average Sentiment Score 62.5

Neutral
기업공시 [7월 23일]
금융지주회사들의 배당 및 자본 조달 결정이 발표되었으나, 티앤엘(340570)에 직접적인 영향은 없다.
Positive
티앤엘, 794만주 무상증자 결정
티앤엘의 무상증자 결정으로 주주가치 증대 기대

Detailed Momentum

52-week position5.0Point

52w mid range (54%)

Current 55,600Won52-week high 65,50052-week low 43,550

1-month return4.0Point

1m +4.51% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주요사항보고서(무상증자결정)2026-07-23
Neutral주권매매거래정지 (무상증자)2026-07-23